Available studies (212 found)
Short citation | Full citation | Bioassay | Epidemiology | Epi. meta-analysis | In vitro | Ecology |
---|---|---|---|---|---|---|
ECHA 1995, 6386950 | ECHA. Registration dossier: (S,S)-1,1,1,2,2,3,4,5,5,5-decafluoropentane; reaction mass of: (R,R)-1,1,1,2,2,3,4,5,5,5-decafluoropentane (CASRN: 138495-42-8): Acute Toxicity: inhalation: 002 Supporting | Experimental result. HERO | |||||
ECHA 1996, 6386949 | ECHA. Registration dossier: (S,S)-1,1,1,2,2,3,4,5,5,5-decafluoropentane; reaction mass of: (R,R)-1,1,1,2,2,3,4,5,5,5-decafluoropentane (CASRN: 138495-42-8): Acute Toxicity: inhalation: 001 Key | Experimental result. HERO | |||||
ECHA 1996a, 6386712 | European Chemicals Agency (ECHA). Registration dossier: (S,S)-1,1,1,2,2,3,4,5,5,5-decafluoropentane; reaction mass of: (R,R)-1,1,1,2,2,3,4,5,5,5-decafluoropentane (CASRN: 138495-42-8): Repeated dose toxicity: inhalation: 001 Key | Experimental result. HERO | |||||
ECHA 1997, 6385545 | European Chemicals Agency (ECHA). Registration dossier: 1,6-diiodoperfluorohexane (CASRN: 375-80-4): Repeated dose toxicity: oral: Supporting | Experimental result. HERO | |||||
ECHA 1997, 6386944 | ECHA. Registration dossier: (S,S)-1,1,1,2,2,3,4,5,5,5-decafluoropentane; reaction mass of: (R,R)-1,1,1,2,2,3,4,5,5,5-decafluoropentane (CASRN: 138495-42-8): Neurotoxicity: 003 Supporting | Experimental result. HERO | |||||
ECHA 1998, 6385615 | ECHA. Registration dossier: 3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane (CASRN: 297730-93-9): Repeated dose toxicity: inhalation: Key | Experimental. HERO | |||||
ECHA 1999, 6385621 | ECHA. Registration dossier: 3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane (CASRN: 297730-93-9): Acute Toxicity: oral: Key | Experimental result. HERO | |||||
ECHA 2000, 6385473 | ECHA. Registration dossier: 1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl )-3-pentanone (CASRN: 756-13-8): Acute Toxicity: inhalation: 001 Key | Experimental result (JS Member). HERO | |||||
ECHA 2000, 6385614 | European Chemicals Agency (ECHA). Registration dossier: 3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane (CASRN: 297730-93-9): Repeated dose toxicity: oral: Key | Experimental result. HERO | |||||
ECHA 2001, 6385461 | European Chemicals Agency (ECHA). Registration dossier: 1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl )-3-pentanone (CASRN: 756-13-8): Repeated dose toxicity: inhalation: 001 Key | Experimental result (JS Member). HERO | |||||
ECHA 2001, 6385469 | ECHA. Registration dossier: 1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl )-3-pentanone (CASRN: 756-13-8): Specific investigations: other studies: 001 Key | Experimental result (JS Member). HERO | |||||
ECHA 2001, 6385471 | ECHA. Registration dossier: 1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl )-3-pentanone (CASRN: 756-13-8): Acute Toxicity: oral: 001 Key | Experimental result (JS Member). HERO | |||||
ECHA 2001, 6385492 | ECHA. 3,3,4,4,5,5,6,6,7,7,8,8-dodecafluorodeca-1,9-diene (CASRN: 1800-91-5): Acute toxicity: inhalation. (CAS No. 1800-91-5). HERO | |||||
ECHA 2001, 6385691 | ECHA. Registration dossier: (E)-1,1,1,2,3,4,5,5,5-Nonafluoro-4-(trifluoromethyl)pent-2-ene (CASRN: 3709-71-5): Acute Toxicity: inhalation: 002 Supporting | Experimental result. HERO | |||||
ECHA 2002, 6385537 | ECHA. Registration dossier: 1,1,2,2,3,3,4,4-octafluoro-1,4-diiodobutane (CASRN: 375-50-8): Acute Toxicity: inhalation: 001 Key | Experimental result. HERO | |||||
ECHA 2002, 6385551 | ECHA. Registration dossier: Dichloromethyl(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)silane (CASRN: 73609-36-6): Acute Toxicity: oral: Key | Experimental result. HERO | |||||
ECHA 2004, 6385682 | European Chemicals Agency (ECHA). Registration dossier: (E)-1,1,1,2,3,4,5,5,5-Nonafluoro-4-(trifluoromethyl)pent-2-ene (CASRN: 3709-71-5): Repeated dose toxicity: oral: Key | Experimental result. HERO | |||||
ECHA 2004, 6385684 | European Chemicals Agency (ECHA). Registration dossier: (E)-1,1,1,2,3,4,5,5,5-Nonafluoro-4-(trifluoromethyl)pent-2-ene (CASRN: 3709-71-5): Repeated dose toxicity: inhalation: 002 Supporting | Experimental result. HERO | |||||
ECHA 2004, 6385689 | ECHA. Registration dossier: (E)-1,1,1,2,3,4,5,5,5-Nonafluoro-4-(trifluoromethyl)pent-2-ene (CASRN: 3709-71-5): Acute Toxicity: oral: Key | Experimental result. HERO | |||||
ECHA 2006, 6385574 | ECHA. Registration dossier: 1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluorooctane (CASRN: 80793-17-5): Acute Toxicity: oral: Key | Experimental result. HERO | |||||
ECHA 2007-2010, 6373310 | European Chemicals Agency (ECHA). Registration dossier 1: 1,1,1,3,3,3-hexafluoropropan-2-ol (CASRN: 920-66-1): Repeated dose toxicity: oral: Key | Experimental result. HERO | |||||
ECHA 2007, 6385570 | European Chemicals Agency (ECHA). Registration dossier: 1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluorooctane (CASRN: 80793-17-5): Repeated dose toxicity: oral: Key | Experimental result. HERO | |||||
ECHA 2007, 6385575 | ECHA. Registration dossier: 1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluorooctane (CASRN: 80793-17-5): Acute Toxicity: inhalation: Key | Experimental result. HERO | |||||
ECHA 2007, 6385695 | ECHA. Registration dossier: 2-Pentene, 1,1,1,2,3,4,5,5,5-nonafluoro-4-(trifluoromethyl)-, (E)- (CASRN: 3709-71-5): Acute Toxicity: inhalation: Key | Experimental result. HERO | |||||
ECHA 2007a, 6385402 | European Chemicals Agency (ECHA). Registration dossier: 1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl )-3-pentanone (CASRN: 756-13-8): Repeated dose toxicity: inhalation: 002 Key | Experimental result (JS Member) (Opt-out). HERO |
Showing studies 51-75 of 212